Human Papillomavirus Type 33 Vaccine

Human Papillomavirus Type 33 Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.

Human Papillomavirus Type 33 Vaccine is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) type 33. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Type 33 which are produced by separate fermentations in recombinant Saccharomyces cerevisiae and self-assembled into VLPs.

Trade Name Human Papillomavirus Type 33 Vaccine
Generic Human papillomavirus type 33 L1 capsid protein antigen
Human papillomavirus type 33 L1 capsid protein antigen Other Names L1 protein, Human papillomavirus type 33 Vaccine, Recombinant human papillomavirus type 33 L1 protein
Type
Groups Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Human Papillomavirus Type 33 Vaccine
Human Papillomavirus Type 33 Vaccine

Innovators Monograph

You find simplified version here Human Papillomavirus Type 33 Vaccine

*** Taking medicines without doctor's advice can cause long-term problems.
Share